T1	Participants 11 62	statins on progression of subclinical brain infarct
T2	Participants 348 426	post-hoc analysis of the Regression of Cerebral Artery Stenosis (ROCAS) study.
T3	Participants 439 689	ROCAS study is a randomized, double-blind, placebo-controlled study evaluating the effects of simvastatin 20 mg daily upon progression of asymptomatic middle cerebral artery stenosis among stroke-free individuals over 2 years. A total of 227 subjects
T4	Participants 972 1025	Among the 227 randomized subjects, 33 (14.5%) had SBI
